White House testing strategy
2020-10-07 15:53:58.805494+00 by Dan Lyke 0 comments
Sigh. White House based their strategy on COVID-19 tests which are for verifying the infection after the onset of symptoms. New York Times: The White House Bet on Abbott’s Rapid Tests. It Didn’t Work Out.
Other health experts noted that the tests deployed by the White House, manufactured by Abbott Laboratories, were given emergency clearance by the Food and Drug Administration only for people “within the first seven days of the onset of symptoms.” But they were used incorrectly, to screen people who were not showing any signs of illness. Such off-label use, experts said, further compromised a strategy that presumably was designed to keep leading officials safe from a pandemic that so far has killed more than 210,000 Americans.